Please rate the following:
Overall quality of the meeting
The program was relevant to my work
Content matched stated objectives
Please rate how well the following objective was met:
Describe how health information displayed in a meaningful manner can change behavior.
Please rate how well the objective was met:
Describe how to build an implementation plan.
Describe how to maintain momentum and corporate commitment under slow market adoption.
Discuss how emphasizing the pre-launch and initial launch within the project lifecycle achieves greater organizational effectiveness and efficiency.
Identify the health care reform strategies to impact the sickest populations that consume the most resources.
Compare proposals to address universal coverage and the fiscal stability of Medicare.
List new market solutions and technologies that build value and transform the industry.
Identify market strategies to foster and achieve accountable care.
Discuss how the retail market is shifting to meet the needs of health care consumers.
Discuss the update on Health Vault's launch and address the implementation challenges for PHRs.
List critical elements of implementing a process and systems engineering strategy.
Identify benefit structures and tools to engage and assist sick consumers.
Identify NYBGH's employer strategies to measure and deliver quality care.
Please rate how well the folllowing objective was met:
Assess the progress of DHHS' focus on value-based purchasing.
Identify the key elements of a health care system that would provide cost-effective care.
Please rate how well the following objectives were met:
Describe how Boeing uses its leverage to align purchasing of over $2.1 billion in health care.
Discuss the impact on high cost, targeted therapies and diagnostic testing on payers, purchasers and consumers.
Usefulness of handouts/AV
Name critical market dynamics and key elements of sustainable business models to achieve true innovation in health care.
Identify CMS's advances toward value-based purchasing models and tying reimbursement to quality.
Discuss the impact of health care in Africa.
Identify implications of social networking on health information privacy.
Discuss the impact of an interactive and proactive web-based information clearinghouse to participating states.
Describe how employer, plan and provider efforts toward transparency are converging and how quickly consumers will benefit.
Explain the lessons learned from international expansion and new geographic markets.
Discuss C-Path's progress on accelerating development of lifesaving therapies for cancer patients.
Discuss the progress toward implementing systems and driving culture exchange to meet CMS, payer and employer quality measures.
Discuss the status of Congress in regulating the use of imaging in physician-owned specialty hospitals.
Discuss transforming care management strategies for improved chronic care management.
List specific incentives and strategies for an effective medical home..
Name results from sustainable RHIOs to improve data flow and care coordination.
Define analysis of state programs and implementation results that provide insights to viable program design.
Discuss how to engage upper management in a value-based benefit design and quantifying the avoidable costs.
Forecast the impact of new market entrants and technology/internet plays on the health plan sector.
Discuss integrating better risk information based on actual experience with new drugs to signal potential risks and target follow-up clinical studies.
Discuss the interface of EMRs and reimbursement..
Identify EMR Implementation Strategies for Improved ROI.
Explain the impact of global public health concerns for multinational corporations' workforce.
List the challenges in achieving interoperability in a best-of-breed environment.
Review the results from Minnesota demonstrating the impact of public disclosure on provider quality measures.
Discuss the use of health IT to further community efforts for wellness.
List strategies for routine data analysis to determine coverage needed to establish recontracting priorities.
Examine provider payment reform and global case rates.
Identify approaches and tools used by domestic and international health systems to measure the value of innovation and implications on pricing and reimbursement.
Name proven health system strategies to dramatically reduce the variation in care through IT adoption and physician adherence to evidence-based medicine.
Define the strategies and incentives to drive physician and clinician technology adoption to dramatically improve quality and reporting efforts.
Illustrate sophisticated provider-led co-morbidity management programs.
Describe how retail care can be a necessary payer product to deliver consumer-focused care.
List trends in consumer demand and usage patterns for PHRs.
Discuss outcomes from benefit design offerings to include analyses of diagnoses.
Address current and future strategies to overcome communication challenges.
Discuss value-based benefit design to include services that identify numerous preventable chronic conditions.
Employ appropriate technology and communication methods for continuity of care.
Discuss updates on consumer tools to improve health status and change behavior.
Define roll out strategies to expand the scope and depth of Aetna's transparency model for cost and quality.
Discuss the Health Savings Account Council's role as a direct conduit of information between industry and legislation.
Describe how employers, plans and providers collaborate to develop a robust diabetes education, intervention and care coordination program.
Apply technology to engage consumers that results in improved outcomes for chronic diseases.
List effective models for physician and clinician-led chronic care management.
Demonstrate strategies and tools to deliver pharmacy information and counseling to consumers.
Evaluate coverage and reimbursement strategies of public and private payers for new medical devices and diagnostics.
Define strategies to measure and report on quality, consumer engagements, and public disclosure.
Discuss application of NICEs cost-effectiveness research within the UK's National Health Service.
Discuss privacy regulations to ensure security of personal health information.
Identify key program design elements and incentives to change behavior.
Describe Boeing's progressive implementation of a chronic care delivery model that applies lean manufacturing to physician practice operations for evidence-based chronic care treatment.
Describe how to launch interoperable, payer-based personal health record, where claims data follows consumers.
Substantiate reimbursement for diagnostics and therapeutics based on market principles by demonstrating significantly enhanced outcomes.
Define MedPAC's ruling to change DRGs to close the gap between reimbursement and cost of providing care.
Discuss PQRI's progress to establish meaningful financial incentives for quality reporting and future directions.
Explain an employer approach to progressive (and somewhat controversial) health benefit design to ensure health promotion.
Comfort of rooms
Discuss results on the growth and forecasts for medical travel – Competitive differentiators, leading providers and forging international partnerships.
Discuss implementation challenges of HL7's latest version including data on improved outcomes.
Describe how to populate a data warehouse with phenotypic and genomic information.
Discuss the impact of the UK's National Institute of Clinical Excellence to implement coverage decisions based on cost-effectiveness research.
List integration strategies for DM and wellness programs and measure value to produce better outcomes.
Name new disease management and wellness models to target interventions and manage the most costly members.
List strategies to work collaboratively with providers and payers while offering convenience to consumers.
Discuss implementation challenges to design, populate and distribute portable electronic records to consumers.
Identify evolving models of care focusing on complex co-morbidities.
How well did the educational sessions give a balanced view of therapeutic options, including the use
of generic names?
Do you believe this activity:
increased your professional knowledge?
will increase your professional competence?
will result in performance changes in your professional practice?
was appropriate for the scope of your professional activities?
will result in your ability to improve your practice?
Was the educational content scientifically sound?
If faculty spoke about off-label or investigational uss of a product, was that information disclosed to you?
Was the mode of education effective to learning?
Were you solicited by sales pesonnel in an educatonal room while you attended this educational activity?
List any perceived practice "gaps" which you would like to see the focus of future trainings.
Are you interested in basic, intermediate or advanced level trainings?
What barriers might you have that would interfere with implementation of new information learned from this training?
How can this training be improved to impact your competence or practice?
Please list any educational needs/topics you would like to see addressed in future meetings.
Additional comments:
